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The chemical structure ofhydroxylated diphenylalkanes or bisphenols consists oftwo phenolic
rings joined together through a bridging carbon. This class ofendocrine disruptors that mimic
estrogens iswidely used in industay, particularly in plastics. Bisphenol F, bisphenol A, fluorine-
containing bisphenol A (bisphenol AF), and other diphenylalkanes were found to be estrogenic
in a bioassay with MCF7 human breast cancer cells in culture (ESCREEN assay). Bisphenols
promoted cell proliferation and increased the synthesis and secretion ofcell type-specific pro-
teins.'When rankedbyproliferaitivepotency, thelonger thealkl substituent at the bridging car-
bon, the lower theconcentration neded formaximal cell yield; the most active compound con-
tained two propyl chains at the bridging carbon. Bisphenols with two hydrox groups in the
paraposition and anangularconfigurtion are suitable for appropriate hydrogen bondingto the
acceptor site ofthe estrogen receptor. Our data suggest that estrogenicity is influenced not only
by the length of the substituents at the bridging carbon but also by their nature. Because
diphenylalkane derivatives arewidespread and their production and use are increasing potential
exposure ofhumans to estrogenic bisphenols is becoming a significant issue. The hazardous
effects ofinadvertent exposure to bisphenol-releasing chemicals in professional workers and the
general populations therefore deserve investigation. Key wordr. bisphenol A, bisphenol F,
endocrine-disrupting chemicals, hydroxylateddiphenylalanes, MCF7 breast cancer cells, xenoe-
strogens. EnvironHealthPeect106:167-174 (1998). [Online 5 February 1998]
htap://ehpnetl.niehs.nih.gov/d,oes/l9981106p167-174perdabstract.html
There is increasing evidence that organic
molecules of different chemical structures,
with a variety ofindustrial applications, are
acting on living organisms and disrupting
their endocrine systems (1). The chemical
structure of one class of endocrine disrup-
tors that mimic estrogens consists of two
phenolic rings joined together through a
bridging carbon. These diphenylalkanes
have received the generic name bisphenols:
bisphenol F (BPF) when the bridging car-
bon has no substituent, bisphenol A (BPA)
when the bridging group contains two
methyl groups, or bisphenol AF when the
methyl groups ofbisphenol A are perfluori-
nated (2).
Diphenylalkanes are currently among
the leading chemicals in plastics (3), and
BPA is a primary raw material for the pro-
duction of polycarbonates, epoxy resins,
phenolics resins, polyesters, and polyacry-
lates. Polycarbonates, which have become
the most widely used material in engineered
plastic, account for about 60% of total
demand for BPA. In 1995, nearly 1.4 bil-
lion pounds (W700 x 106 kg) ofthis bisphe-
nol were produced.
Epoxy resins, obtained by the reaction of
bisphenols with epichlorohydrin, are the
fundamental components ofhigh commer-
cial-quality polymer materials (4). These
very transparent resins display good
mechanical resistance and conserve their
form at a wide range oftemperatures, per-
mitting the production ofsterilizable mate-
rials. Epoxy-based coatings are used in
many applications including product fin-
ishing, marine finishing, decorative floor
manufacture, breaking petroleum emul-
sions, structural steel coating, lacquer coat-
ings in cans and othervessels used for food-
stuffs, tank coating, can and drum linings,
and floorvarnishes. They are also employed
in dental composites and sealants and used
as additives for a variety of other plastic
materials such as vinyl and acrylic resins
and natural andsynthetic rubber.
In 1909, L.H. Baekeland patented the
first phenolic plastic, known as bakelite
(3). This material was produced by a reac-
tion between phenol and formaldehyde
which gives rise to BPF. Phenolic resins are
produced by the copolymerization of sim-
ple phenols or bisphenols and formalde-
hyde. For example, polyformal II is made
from perfluorinated BPA and formalde-
hyde (5). Coatings based on phenolic
resins are tough, have excellent adhesion,
and are used in inks, coatings, varnishes,
and abrasive binders.
The first published reports on estro-
genic effects ofhydroxylated diphenylalka-
nes appeared in the 1930s. In 1936, Dodds
and Lawson (6) reported the estrogenicity
of some diphenyl compounds containing
two hydroxyl groups in para positions. Reid
and Wilson (7) subsequently confirmed the
estrogenicity of 4,4'-dihydroxydiphenylal-
kane derivatives. In 1987, Morrisey et al. (8)
analyzed the developmental toxicity ofBPA
in rats and mice. Citing a study conducted
by Hardin from the National Institute for
Occupational Safety and Health, Morrisey
suggested that BPA exerted an estrogenic
effect in ovariectomized rats. More recently,
BPA released from polycarbonate flasks dur-
ing autoclaving was also shown to have an
estrogenic effect (55.
In recent years we identified routes of
human exposure to BPA. We first demon-
strated the presence ofestrogenic activity in
canned foodstuffs and identified the estro-
genic component BPA as a chemical leach-
ing from the inner plastic coating (10). BPA
was present at concentrations ranging from
4 to 23 pg/can in both extracted foods and
water from autoclaved cans. Subsequently,
we demonstrated that the estrogenicity of
some commercial composites and sealants
used in dentistry was due to their BPA con-
tent. We found BPA and related com-
pounds in saliva after standard dental treat-
ments (11). Recently, we proposed to deter-
mine whether epoxy resins and polycarbon-
ates contribute to the inadvertent and
unsuspected exposure of humans to estro-
genicxenobiotics (12).
As a follow-up of our previous work
(10,11), we studied whether BPA-derived
compounds with substitution of the
hydroxy groups and the central carbon
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atom are estrogenic and tested the prolifer-
ative effect of BPA and structurally similar
molecules commonly employed in plastic
materials in MCF7 breast cancer cells. We
also studied the potency of these com-
pounds in inducing cell type-specific pro-
teins (progesterone receptor and pS2) and
their affinity to bind to the estrogen recep-
tor extracted from immature rats.
Materials and Methods
Chemicals. 17p-estradiol (E2) and diethyl-
stilbestrol (DES) were purchased from
Sigma Chemical Co. (St. Louis, MO).
Various diphenylalkanes with substituents
at the central carbon or the hydroxy groups
were either purchased or synthesized by one
of us (M.M.) (see Table 1 for structure).
BPA, BPF, bisphenol A dimethacrylate
(BisDMA), bisphenol A bischloroformate
(BPACF), bisphenol A ethoxylate (E-BPA),
bisphenol A propoxylate (P-BPA), bisphe-
nol A ethoxylate diacrylate (BPA-EDA),
bisphenol A diglycidylether (BADGE), and
bisphenol A diglycidylether dimethacrylate
(Bis-GMA) were obtained from Aldrich
(Aldrich-Chemie, Albuch, Germany). 1,1-
Bis(4-hydroxyphenyl)ethane (MM1); 1,1-
bis(4-hydroxyphenyl)propane (MM2); 2,2-
bis(4-hydroxyphenyl)butane (MM3); 3,3-
bis(4-hydroxyphenyl)pentane (MM4); 4,4-
bis(4-hydroxyphenyl)heptane (MM5); 2,2-
bis(4-hydroxy-3-methylphenyl)propane
(MM6); 2,2-bis(4- hydroxyphenyl)perfluo-
ropropane (MM7 or bisphenol AF); bis(4-
hydroxyphenyl)ketone (MM8); and 2,2-
bis(4-hydroxyphenyl)propanol (MM9)
were synthesized by M. Metzler. Purity of
these chemicals was at least 97%. None of
these contained bisphenol A according to
HPLC and GC/MS analysis. Chemicals
were dissolved in ethanol to a final concen-
tration of 1 mM and stored at -20%C.
[2,3,5-3H]-E2 (103 Bq/mmol) was obtained
from Amersham (Buckinghamshire,
England).
Table 1. Chemical characterization, proliferative effect, and induction of cell type-specific proteins in
MCF7 cells, relative binding affinity to the estrogen receptor from rat uterine cytosol, and stoichiometric
measurements ofdiphenylalkanes
R3
Code R1 R2 R3 PEa RpPb RiPPb RBAC 0Ood
E2 NA NA NA 6.7 ± 1.2 100 100 100 10.96
BPF -OH -H -H 7.1 ±0.3 0.001 0.01 0.15 9.29
BPA -OH -CH3 -CH3 6.0 ± 0.5 0.01 0.1 0.056 9.20
BisDMA -OOC-C(CH3)=CH2 -CH3 -CH3 5.6 ± 0.6 0.001 0.01 0.0015 8.87
BPACF -QOCCI -CH3 -CH3 4.6 ± 0.2 0.001 0.01 0.023 9.00
E-BPA -OCH2-CH2OH -CH3 -CH3 0.9 ± 0.1 na na na 9.30
P-BPA -OCH2-CHOH-CH3 -CH3 -CH3 1.0 ± 0.3 na na na 9.28
BPA-EDA-OCH2-CH2-COO- -CH3 -CH3 3.9 ± 0.6 0.0001 <0.01 0.0005 9.81
CH=CH2
BADGE -OCH2-CH-CH2
0 -CH3 -CH3 2.0 ± 0.3 0.0001 na na 9.31
BisGMA -OCH2-CHOH- -CH3 -CH3 1.1 ± 0.1 na na na 8.80
CH20OC-C(CH3)=CH2
MM1 -OH -CH3 -H 6.3 ± 0.4 0.001 0.01 0.0009 9.30
MM2 -OH -C2H5 -H 6.7 ±0.9 0.01 0.01 0.15 9.27
MM3 -OH -C2H5 -CH3 5.9± 0.2 0.01 0.1 0.15 9.27
MM4 -OH -C2H5 -C2H5 7.2± 0.7 0.1 0.1 0.18 9.13
MM5 -OH -C3H7 -C3H7 7.2± 0.8 1 1 0.15 9.12
MM6e -OH -CH3 -CH3 6.8 ± 0.6 0.01 0.1 0.25 9.65
MM7 -OH -CF3 -CF3 5.5 ± 0.6 0.01 0.1 1 9.25
MM8 -OH =O - 5.5 ± 0.4 0.0001 <0.01 0.013 10.21
MM9 -OH -CH2OH -CH3 7.1 ± 0.4 0.0001 <0.01 0.0075 9.25
Abbreviations: PE, proliferative effect; RPP, relative proliferative potency; RIPP, relative induced protein potency; RBA,
relative binding affinity; E2, 17,-estradiol; BPF, bisphenol F; BPA, bisphenol A; BisDMA, bisphenol A dimethacrylate;
BPACF, bisphenol A bischloroformate; E-BPA, bisphenol A ethoxylate; P-BPA, bisphenol A propoxylate; BPA-EDA,
bisphenol A ethoxylate diacrylate; BADGE, bisphenol A diglycidyl ether; Bis-GMA, bisphenol A diglycidylether
dimethacrylate; MM1, 1,1-bis(4-hydroxyphenyl)ethane; MM2, 1,1-bis(4-hydroxyphenyl)propane; MM3, 2,2-bis(4-hydrox-
yphenyllbutane; MM4, 3,3-bis(4-hydroxyphenyl)pentane; MM5, 4,4-bis(4-hydroxyphenyl)heptane; MM6, 2,2-bis(4-
hydroxy-3-methylphenyl)propane; MM7, 2,2-bis(4-hydroxyphenyl)perfluoropropane; MM8, bis(4-dihydroxyphenyl)ketone;
MM9,2,2-bis(4-hydroxyphenyl)propanol; NA,notapplicable; na, no activity.
TPE isexpressed asthe ratio between the highest cellyield obtainedwith the diphenylalkanetested and the hormone-free control.
bRPP and RIPP are 100 xthe ratios between the dose ofE2 and thatofthediphenylalkane neededto produce maximal cell yield and maximal
expression ofcell-type specific proteins, respectively. RPP and RIPP were set at 100for E2,which correspondedto 10pM and 1 nM for maxi-
mal effect on cellyield and induction ofcell-type specific proteins, respectively.
CRBA of each chemical was calculated as the ratio ofthe concentration ofunlabeled E/competitor required to inhibit 50% ofthe specific
[3HI-2binding, with the affinity of E2set at 100%.
d0-0 is the measurement in A ofthe distance between the two oxygen atoms adjacentto the ring.
"Iwo additional CH3 groups in ortho positions tothe hydroxy groups.
MCF7 cellline. The MCF7 breast can-
cer cell line was a gift from C. Sonnenschein
(Tufts University, Boston, MA). For rou-
tine maintenance, cells were grown in
Dulbecco's modification ofEagle's medium
(DME) supplemented with 5% fetal bovine
serum (FBS; PAA Labor und Forschungs
Ges, MBH, Linz, Austria) in an atmosphere
of 5% C02/95% air under saturating
humidity at 37°C. The cells were subculti-
vated at weekly intervals using a mixture of
0.05% trypsin and 0.01 EDTA.
Charcoal-dextran treatment ofserum.
Plasma-derived human serum was prepared
from outdated plasma by adding calcium
chloride to a final concentration of30 mM
to facilitate clot formation. Sex steroids
were removed from serum by charcoal-
dextran stripping (13). Briefly, a suspen-
sion of 5% charcoal (Norit A, Sigma
Chemical Co) with 0.5% dextran T-70
(Pharmacia-LKB, Uppsala, Sweden) was
prepared. Aliquots of the charcoal-dextran
suspension of a volume similar to the
serum aliquot to be processed were cen-
trifuged at 1,000 x g for 10 min. Superna-
tants were aspirated and serum aliquots
were mixed with the charcoal pellets. This
charcoal-serum mixture was maintained in
suspension by rolling at 6 cycles/min at
37°C for 1 hr. The suspension was cen-
trifuged at 1,000 x g for 20 min, and the
supernatant was then filtered through a
0.20 pim filter (Gelman Sciences, Ann
Arbor, MI). Charcoal dextran-treated
human serum (CDHuS) was stored at
-20°C until needed.
Cellproliferation experiments. MCF7
cells were used in the E-SCREEN test of
estrogenicity according to atechnique slight-
ly modified (14) from that originally
described by Soto et al. (15). Briefly, cells
were trypsinized and plated in 24-well plates
(Limbro, McLean, VA) at initial concentra-
tions of 10,000 cells/well in 5% FBS in
DME. Cells were allowed to attach for 24
hr; the seeding medium was then replaced
with 10% CDHuS-supplemented phenol
red-free DME. Different concentrations of
the test compound were added, and the
assay was stopped after 144 hr by removing
medium from wells, fixing the cells, and
staining them with sulforhodamine-B
(SRB). The staining techniquewas modified
from that described by Skehan et al. (16).
Briefly, cells were treated with cold 10%
trichloracetic acid and incubated at 40C for
30 min, washed five times with tap water,
and left to dry. Trichloroacetic-fixed cells
were stained for 10 min with 0.4% (wt/vol)
SRB dissolved in 1% acetic acid. Wells were
rinsed with 1% acetic acid and air dried.
Bound dyewas solubilized with 10 mM Tris
base (pH 10.5) in a shaker for 20 min.
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Finally, aliquots were transferred to a 96-
well plate and read in a Titertek Multiscan
apparatus (Flow, Irvine, CA) at 492 nm.
Linearity ofthe SRB assay with cell number
was verified prior to cell growth experi-
ments. Mean cell numbers from each experi-
ment were normalized to the steroid-free
control cultures to correct for differences in
the initial seeding density. The proliferative
effect (PE) was expressed as the ratio
between the highest cell yield obtained with
the diphenylalkane tested and the hormone-
free control. The relative proliferative poten-
cy (RPP) was calculated as 100 x the ratio
between the dose of E2 and that of the
diphenylalkane needed to produce maximal
cell yield.
Progesterone receptor induction. MCF7
cells seeded in T25 flasks (Nunc, Roskilde,
Denmark) were incubated in 10% CDHuS
for 72 hr with 0.1-10 nM E2, and a paral-
lel set offlasks were exposed to 0.1-10 pM
of the chemicals. Controls received the
vehicle alone. At the end of the experi-
ment, the medium was aspirated and the
cells were frozen in liquid N2. To extract
receptor molecules, cells were incubated
with 1 ml extraction buffer (0.5 M KCI, 10
mM potassium phosphate, 1.5 mM
EDTA, and 1 mM monothioglycerol, pH
7.4) at 40C for 30 min. Progesterone recep-
tors (PgR) were measured in extracted cells
by enzyme immunoassay using the Abbott
progesterone receptor kit (Abbott
Diagnostics, Chicago, IL) according to the
manufacturer's instructions.
Induction and secretion ofpS2. pS2
was measured in the culture medium of
MCF7 cells with the ELSA-pS2 immuno-
radiometric assay (CIS Bio International,
Gif-sur-Yvette, France). Cells were subcul-
tured into 24-well plates for 144 hr in 10%
CDHuS. The culture medium was cen-
trifuged at 1,200 x g for 10 min to elimi-
nate floating and detached cells. Results are
expressed as nanograms ofsecreted protein
per million cells. The relative induced pro-
tein potency (RIPP) was calculated as 100
x the ratio between the dose ofE2 and that
of the diphenylalkane needed to produce
maximal expression of cell-type specific
proteins (pS2 and PgR).
Competitive binding assay. Cytosol
from immature female rat uteri was pre-
pared at a protein concentration ofapproxi-
mately 2 mg/ml in phosphate buffer.
Aliquots ofthis supernatant were then incu-
bated with various concentrations ofchemi-
cals and 3 nM [3H]-estradiol for 16 hr at
0-40C. The free and bound fractions were
separated with the charcoal-dextran tech-
nique. The relative binding affinity (RBA)
of each competitor was calculated as the
ratio of the concentration of unlabeled
estradiol/competitor required to inhibit
50% of the specific [3H]-E2 binding, with
the afflinity ofestradiol set at 100%.
Structural analysis. The Hyperchem
software package (Hyperchem v. 3 for
Windows, 1993; Autodesk Inc, Sausalito,
CA) was used for molecular modeling stud-
ies. Natural (E2) and synthetic estrogens
(DES) as well as diphenylalkanes were con-
structed and then geometrically optimized
to achieve the minimal energy conforma-
tion usingMM+ force fields and to measure
the distance between the oxygen groups.
Statistical analysis. Results were
expressed as the mean ± standard deviation
(SD). Proliferation yield experiments con-
ducted in quadruplicate wells were repeated
at least three times. Mean cell numbers from
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Figure 1. Proliferation (quadruplicate values and standard deviations) of MCF7 cells grown in 10% charcoal
dextran-treated human serum-supplemented medium exposed for 144 hr to E2 and to diphenylalkanes.
Abbreviations: C, control; E2, 1713-estradiol; BPF, bisphenol F; BPA, bisphenol A; BisDMA, bisphenol A
dimethacrylate; BPACF, bisphenol A bischloroformate; E-BPA, bisphenol A ethoxylate; P-BPA, bisphenol A
propoxylate; BPA-EDA, bisphenol A ethoxylate diacrylate; BADGE, bisphenol A diglycidyl ether; Bis-GMA,
bisphenol A diglycidylether dimethacrylate; MM1, 1,1-bis(4-hydroxyphenyl)ethane; MM2, 1,1-bis(4-hydrox-
yphenyl)propane; MM3, 2,2-bis(4-hydroxyphenyl)butane; MM4, 3,3-bis(4-hydroxyphenyl)pentane; MM5,
4,4-bis(4-hydroxyphenyl)heptane; MM6,2,2-bis(4-hydroxy-3-methylphenyl)propane; MM7, 2,2-bis(4-hydrox-
yphenyl)perfluoropropane; MM8, bis(4-dihydroxyphenyl)ketone; MM9, 2,2-bis(4-hydroxyphenyl)propanol.
The x-axis represents concentrations 10-12 (-12), 10-11 (-11), etc. Controls received vehicle alone; E2 was
effective atconcentrations as low as 1 pM (0.272pg/mI).
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each experiment were normalized to the
steroid-free control to correct for differences
in the initial seeding density. Differences
between the different chemical treatment
groups were assessed by analysis ofvariance
and the aposterioriShaffe's test. Ap-value of
<0.05 was regarded assignificant.
Results
Cellproliferation experiments. Addition of
E2 to CDHuS-supplemented medium
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increased the number ofMCF7 cells in the
culture. Maximum proliferative effect was
obtained at concentrations of 10 pM E2 and
higher (Fig. 1). Cell yields were sixfold
greater than in control cultures after 6 days
(mean ± SD = 6.67 ± 1.21 in 15 experi-
ments). In the absence of E2 (control), cells
proliferated minimally. The PE ofdiphenyl-
alkanes is shown in Figure 1 andTable 1. PE
was significantly different from 1 for all the
compounds tested except for the ethoxylate
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Figure 2. Progesterone receptors (PgR) in MCF7 cells, which were incubated in 10% charcoal dextran-
treated human serum for 72 hr with 10-10 (-0), 109 (-9), and 10-8 (-8) M E2. A parallel set of flasks were
exposed to 10-7 (-7), 10-6 (-6), and l0O5 (-5) M diphenylalkanes. Abbreviations: C, control; E2, 17,B-estradiol;
BPF, bisphenol F; BPA, bisphenol A; BisDMA, bisphenol A dimethacrylate; BPACF, bisphenol A bischloro-
formate; E-BPA, bisphenol A ethoxylate; P-BPA, bisphenol A propoxylate; BPA-EDA, bisphenol A'ethoxy-
late diacrylate; BADGE, bisphenol A diglycidyl ether; Bis-GMA, bisphenol A diglycidylether dimethacry-
late; MM1, 1,1-bis(4-hydroxyphenyl)ethane; MM2, 1,1-bis(4-hydroxyphenyl)propane; MM3, 2,2-bis(4-
hydroxyphenyl)butane; MM4, 3,3-bis(4-hydroxyphenyl)pentane; MM5, 4,4-bis(4-hydroxyphenyl)heptane;
MM6, 2,2-bis(4-hydroxy-3-methylphenyl)propane; MM7, 2,2-bis(4-hydroxyphenyl)perfluoropropane; MM8,
bis(4-dihydroxyphenyl)ketone; MM9, 2,2-bis(4-hydroxyphenyl)propanol. Controls received vehicle alone.
At the end of the experiment, the medium was discarded and flasks were kept in liquid N2 until assayed.
PgR was measured in extracted cells with a monoclonal antibody technique as indicated in Methods.
Results are expressed as femtomol per milligram of extracted protein ± standard deviation.
and propoxylate of BPA (E-BPA and P-
BPA) and Bis-GMA, which were negative in
the bioassay. In comparison with the PE of
E2, all these compounds showed a full ago-
nistic response except BPACF, BPA-EDA,
and BADGE, which produced cell yields
below 60% of those found with E2.
Therefore, they behaved as partial estrogen
agonists at the maximal concentration
assayed (10 gM). In addition, estimated
relative proliferative potency (RPP) allowed
us to rank diphenylalkanes by their estro-
genic potency: E2>MM5>MM4>BPA,
MM2, MM3, MM6, MM7>BPF, MM1,
BPACF, Bis-DMA>MM8, MM9, BPA-
EDA, BADGE.
Induction ofprogesterone receptor. The
basal concentration of estrogen receptors
(ER) and PgR in MCF7 cells was 183 ± 29
fmol/mg and 15.5 ± 4.3 fmol/mg ofextract-
ed protein, respectively. E2 increased the
concentration of PgR nearly 10-15-fold
over the basal value (Fig. 2). Exposure of
MCF7 cells to diphenylalkanes and related
compounds resulted in a significant increase
in PgR (Fig. 2). With the exception of
MM8, MM9, E-BPA, P-BPA, and Bis-
GMA, all other chemicals tested increased
the levels of the PgR to a degree similar to
that found with the natural estrogen.
However, the concentration needed for
maximal effect ranged from 0.1 pM for
MM5, the most active compound, to 10
pM for the others. Agood statistical correla-
tion was found between the ability ofthese
chemicals to induce PgR and to increase
MCF7 cell yields in the proliferation bioas-
say (r = 0.908). With the exception of
BADGE, which showed the poorest prolif-
erative effect and was unable to induce PgR
at the maximal concentration tested (10
PM), all other chemicals that induced PgR
were also effective in the proliferation bioas-
say. In addition, the induction of PgR for
MM8 and MM9 was not maximal although
theywere full agonists forproliferation.
pS2 Secretion. pS2 Secretion by MCF7
cells was significantly increased by concen-
trations .0.1 nM E2 (=3.5-fold increase
over controls). The basal concentration of
pS2 (53.6 ± 8.7 ng/106 cells) increased to
179.4 ± 13.1 ng/106 cells after treatment
with 1 nM E2 (Fig. 3). Exposure ofMCF7
cells for 144 hr to various diphenylalkanes
resulted in a significant increase in secreted
pS2 (Fig. 3). A good statistical correlation
was found between the ability of these
chemicals to induce pS2 and to increase
MCF7 cell yields in the proliferation bioas-
say (r= 0.809). Both E-BPA and P-BPA, as
well as bis-GMA and BADGE, were inef-
fective in the induction and secretion of
pS2. BPA-EDA was fully inductory for pS2
and partiallyfor PgRand cell proliferation.
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Relative binding affinities. Relative
binding affinities (RBA) for ER of
diphenylalkanes ranged from 1 (MM7) to
0.0005 (BPA-EDA) (Fig. 4; Table 1). As
suspected, E-BPA, P-BPA, and Bis-GMA
showed no affinity for binding to the ER,
even at concentrations 1 million-fold high-
er than those of E2. A good relationship
was found between the RBA estimated in
the uterine cytosol assay and the prolifera-
tive potencies ofeach compound using the
MCF7 breast cancer cell proliferation
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bioassay (r = 0.842). This result suggested
that the proliferative effect ofdiphenylalka-
nes was mediated through their binding to
the ER. However, a discrepancy between
receptor affinity and proliferative ability
was observed; BADGE was a partial ago-
nist in the E-SCREEN assay, showing no
affinity for binding to the uterine ER.
Chemicalstructure. Structures ofnatur-
al and synthetic estrogens and estrogenic
xenobiotics can be compared by measuring
the distance between the two oxygen atoms
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Figure 3. Accumulation of pS2 in culture medium. MCF7 cells were grown in 10% charcoal dextran-treated
human serum-supplemented medium and exposed for 144 hr to 10-10 (-10), 10-9 (-9), and 10-8 (-8) M E2.
Parallel cultures were exposed to 10-7 (-7), 10-6(-6), and 10-5(-5) M diphenylalkanes. Abbreviations: C, con-
trol; E2, 17p-estradiol; BPF, bisphenol F; BPA, bisphenol A; BisDMA, bisphenol A dimethacrylate; BPACF,
bisphenol A bischloroformate; E-BPA, bisphenol A ethoxylate; P-BPA, bisphenol A propoxylate; BPA-EDA,
bisphenol A ethoxylate diacrylate; BADGE, bisphenol A diglycidyl ether; Bis-GMA, bisphenol A digly-
cidylether dimethacrylate; MM1, 1,1-bis(4-hydroxyphenyl)ethane; MM2, 1,1-bis(4-hydroxyphenyl)propane;
MM3, 2,2-bis(4-hydroxyphenyl)butane; MM4, 3,3-bis(4-hydroxyphenyl)pentane; MM5, 4,4-bis(4-hydrox-
yphenyl)heptane; MM6, 2,2-bis(4-hydroxy-3-methylphenyl)propane; MM7, 2,2-bis(4-hydroxyphenyl)perfluo-
ropropane; MM8, bis(4-dihydroxyphenyl)ketone; MM9,2,2-bis(4-hydroxyphenyl)propanol. Controls received
vehicle alone. Results are expressed as nanograms per million cells ± standard deviation.
responsible for hydrogen bonding to the
acceptor site of the estrogen receptor. The
0(3)-0(17) interatomic distance for E2
was 10.96 A, and the 0(4)-0(4) distance
of the synthetic estrogen DES was 12.1 A.
The various diphenylalkanes listed in Table
1 showed an 0(4)-0(4) interatomic dis-
tance that ranged from 8.80 to 10.21 A,
slightly less than in E2. Differences in
estrogenic activity among the dipheny-
lalkyls tested seemed to be dependent on
the type of radical incorporated to the
bridging carbon and the distance between
the bonding groups.
Discussion
BPF, BPA, bisphenol AF, and other
diphenylalkanes are estrogenic in MCF7
cells, promoting cell proliferation and
increasing the synthesis and secretion ofcell-
type specific proteins. When ranked by pro-
liferative potency, the longer the alkyl sub-
stituent at the bridging carbon, the lower
the concentration needed to give maximal
cell yield; the most active molecule was that
with two propyl chains at the central car-
bon, i.e., MM5. These results are in agree-
ment with those reported in 1944 by Reid
and Wilson (7), who showed the propyl-
propyl derivative, within a wide series of
4,4'-dihydroxydiphenylmethane derivatives,
as the most potent estrogenic compound in
vivo, when using the uterine test.
Dodds and Lawson (6) were the first to
note that the phenanthrene condensed-ring
structure was not necessary for estrogenic
activity. Recently, by studying correspon-
dence factor analysis to structure-activity
relationships, Gilbert et al. (17) suggested
that, in the diphenylalkanes, both phenyl
rings are needed to display substantial pro-
liferative activity in MCF7 cells and that
the phenyl groups should be separated by
at least a single carbon or preferably by two
carbons. However, the estrogenicity of
some alkylphenols bearing only one phenyl
ring was demonstrated some years ago by
Soto et al. (18), who showed that alkylphe-
nols with at least a three-carbon alkyl chain
in the para position had a proliferative
effect on MCF7 cells (19). Soto and co-
workers (19) also showed that fused rings
such as naphthols are not estrogenic,
despite being an integral part ofthe A and
B ring of natural steroids and that some
polychlorinated biphenyls promoted prolif-
eration in MCF7 cells.
Among factors that make a molecule
estrogenic, Leclercq (20) found that the
existence of an oxygen functional group
(hydroxylic, ketonic, or carbonyl) located
at the end of the molecule opposite the
phenolic ring conferred or at least ampli-
fied estrogenicity. It is now clear that this
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group is present in the doisynolic acid
derivatives as a carbonyl group (19) and in
DDT and some polychlorinated biphenyls
as chlorine residues susceptible to hydroxy-
lation (21). In terms ofchemical structure,
the diphenylalkanes assayed in this study
carry two terminal hydroxyl groups in the
para position, either free (BPA, BPF, and
MM1 to MM9) or as ether or ester bonds.
Ester derivatives of diphenylakanes (Bis-
DMA and BPACF) were estrogenic in the
proliferation and protein induction assays,
in contrast to some ether substituents at
the terminal -OH (E-BPA, P-BPA, and
Bis-GMA) that showed no estrogenic activ-
ity in the range ofconcentrations tested.
It has been pointed out that the prolifer-
ative activity of diphenylalkanes is reduced
when the para-hydroxy groups are replaced
by diethylaminoethoxy substituents (17),
but experimental data suggest that ester and
ether type bonds can be deaved by MCF7
cells, releasing para-hydroxy groups and
activating theirestrogenicity. This seemed to
be the case for BADGE and BPA-EDA,
which were estrogenic in the proliferation
100
bioassay at high concentrations (10 pM)
even though they showed very low (BPA-
EDA) and no bindingaffinity (BADGE) for
the estrogen receptor. Thus estrogenicity
could be related to the ability of cellular
enzymatic systems to break down these
bonds and to generate molecules with free
hydroxyl groups. Metabolization ofBADGE
to release a more active compound in the E-
SCREEN assay suggests that the results of
receptorbinding assays should be considered
with caution when assessing estrogenicity.
More recently Mariotti et al. (22) reported
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Figure 4. Competitive displacement of 13H]-E2 from the estrogen receptor by unlabeled E2 and diphenylalkanes. Abbreviations: E2, 17P-estradiol; BPF, bisphenol F;
BPA, bisphenol A; BisDMA, bisphenol A dimethacrylate; BPACF, bisphenol A bischloroformate; E-BPA, bisphenol A ethoxylate; P-BPA, bisphenol A propoxylate;
BPA-EDA, bisphenol A ethoxylate diacrylate; BADGE, bisphenol A diglycidyl ether; Bis-GMA, bisphenol A diglycidylether dimethacrylate; MM1, 1,1-bis(4-hydrox-
yphenyl)ethane; MM2, 1,1-bis(4-hydroxyphenyl)propane; MM3, 2,2-bis(4-hydroxyphenyl)butane; MM4, 3,3-bis(4-hydroxyphenyl)pentane; MM5, 4,4-bis(4-hydrox-
yphenyl)heptane; MM6, 2,2-bis(4-hydroxy-3-methylphenyl)propane; MM7, 2,2-bis(4-hydroxyphenyl)perfluoropropane; MM8, bis(4-dihydroxyphenyl)ketone; MM9,
2,2-bis(4-hydroxyphenyl)propanol. The estimated relative binding affinities of diphenylakanes are shown in Table 1. [3H]-E2 concentration was38 nM,total bind- ing was 58fmol/mg protein, and the dissociation constant Kd = 1.2 x 10-10 M.
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the estrogenicity in vivo of Bis-GMA using
the uterotropic assay.
Lewis et al. (23) postulated that two
hydroxy groups of E2 take part in binding
to the acceptor site ofthe estrogen receptor
by hydrogen bonding. Various diphenyl-
alkanes with two hydroxyl groups but dif-
ferent substituents at the central carbon
atom that cause different angular configu-
ration were tested in our study. In view of
the structural similarities of the molecules
assayed, we performed a computer-based
study of the structure-function relation-
ships. Although this could be a useful alter-
native, current knowledge does not allow
the estrogenic effect of xenobiotics to be
dependably predicted on the basis ofstruc-
tural data. Nevertheless, the combination
of biological assays and structural analyses
allows us to draw some preliminary conclu-
sions (24,25).
Our experimental data suggested that
not only the distance between para-
hydroxy groups but also the nature of the
bridging carbon substituents may deter-
mine estrogenicity. Among the MM com-
pounds, for example, MM8 [bis(4-hydrox-
yphenyl)ketone] is more polar than the
other compounds because of its carbonyl
group; this compound showed the poorest
proliferative effect, which implies that a
lower polarity enhances estrogenicity. No
single structural feature seems to define
estrogenic activity; as proposed by Gilbert
et al. (17), hydrophobic volume together
with hydroxy groups and conjugation with
basic groups are involved in the triggering
ofcell proliferation.
The introduction of methyl groups in
the meta position ofthe aromatic ring, i.e.,
MM6, did not modify estrogenicity. This
suggests that the effect of methyl sub-
stituents in bisphenols is not comparable to
the dramatic reduction of estrogenicity
caused by the introduction of methyl
groups into 2- and 4- position of the A-
ring ofE2 (26).
The estrogenicity of bisphenol poly-
mers may be due to their nonpolymerized
monomers or by chemical degradation.
Polycarbonates and epoxy resins can be
mechanically and thermally degraded, and
these are major problems in their applica-
tion (27). Scrap polycarbonate resins can
be depolymerized by heating in an alkaline
milieu to generate BPA (28). In fact, BPA
was released from polycarbonate flasks (9)
and resin-coated food cans and containers
(10,29) during autoclaving and from
incompletly cured resins (11). Our results
suggest that BADGE, a monomer ofepoxy
resins, becomes estrogenic at a high con-
centration (10 pM), even before hydrolytic
treatment. BADGE and BPF diglycidyl
ether (BFDGE) have short half-lifes (less
than 2 days) in acidic media, and half-life
decreases further with increasing tempera-
ture (30). These findings suggest that the
biological activity of by-products of
BADGE and BFDGE should be consid-
ered when toxicity of the parent com-
pounds is being assessed.
Litde is known about the metabolism of
BPA polymers or BPA itself in animals.
More attention has been paid to epoxy
compounds because of their alkylating
properties (31-34). Interestingly, Climie et
al. (35,36) studied the metabolic degrada-
tion of [14C]-BADGE in mice after oral
administration ofa single dose. They found
that 90% of the radioactivity was eliminat-
ed in the feces and urine during the first 3
days ofthe experiment. A small amount of
BADGE (=5%) underwent oxidative
dealkylation to give glycidaldehyde (which
has alkylating properties) and BPA, among
other products. The systemic behavior of
BPA and other bisphenols is poorly known
and needs further investigation.
The environmental biodegradation of
BPA by strain MV1 ofGram-negative bac-
teria was recently studied (37,38). This
bacteria is able to grow in media with BPA
as the only carbon source. The products of
biodegradation include 60% CO2 and
20% of phenolic derivatives such as 4-
hydroxybenzoic acid, 4-hydroxybenzophe-
none, and molecules such as trans-4-
4'dihydroxystilbene, clearly identified with
high performance liquid chromatography.
Although these processes have been tested
only in microorganisms, they reflect a new
relationship between BPA and molecules
with putative estrogenic effect.
Recently, valuable information about
genetic differences in suceptibility to BPA
(39), effects on new BPA-target organs
beyond the obvious ones of breast and
uterus, and effects on the prostate of the
developing fetus (40) indicate that BPA
appears to be more estrogenic in vivo than
predicted in in vitro assays (41,42).
In summary, experimental data suggest
that thermal, chemical, and enzymatic
degradation ofdiphenylalkanes is a frequent
event. Unpolymerized and degraded BPF-,
BPA-, and bisphenol AF-based polymers
represent a source of biologically active
monomers. Because diphenylalkane deriva-
tives are widespread and their production is
increasing, potential exposure to estrogenic
diphenylalkanes both in the workplace and
the home environment is becoming a sig-
nificant issue. The hazardous effects ofcon-
tinuous exposure to bisphenol-releasing
chemicals in exposed workers and in general
populations demand investigation. We need
to know to what extent human populations
are exposed to bisphenols, how much is
absorbed daily, how these compounds
behave inside the human body, how they
are metabolized, and what effects they have
on human health. Meanwhile, diphenyalka-
nes should be regarded as estrogenic xeno-
biotics, and measures against inadvertent
exposure should be implemented.
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